Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jennifer Doudna
Research
Nobel Laureate Jennifer Doudna enters AI protein design arena
In a new paper, Doudna’s team described a new platform for generating novel gene editing enzymes.
Darren Incorvaia
Jul 16, 2026 2:00pm
In vivo gene editing biotech blossoms from Jennifer Doudna's lab
Nov 4, 2025 8:00am
Center launches with $20M to create CRISPR therapies for kids
Jul 8, 2025 11:59am
CRISPR pioneer Doudna allies with Danaher on gene editing center
Jan 9, 2024 9:17am
Chromosome loss from CRISPR-Cas9 stopped by swapping steps
Oct 9, 2023 7:40am
Scribe's CRISPR tech Prevails with new $1.5B Lilly biobucks deal
May 16, 2023 9:00am
